Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Learn what to expect in a beginner investment consultation to maximize your experience. Get ready to take charge of your investments.
20,082 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Paramount’s theater commitments could reshape local economies nationwide by expanding film production and theater act...
Insider moves can reveal more than a single trade. This article breaks down the photonics director sells 1,511, expla...
Investors want a clear compass for Alphabet stock in the next five years. This article breaks down the growth drivers...
Two gig-economy giants sit on the stock market while AI reshapes their path. This guide compares Fiverr stock Upwork ...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...
Meta leans on ad-driven growth and in-house AI monetization to push margins higher, while Intel navigates heavy capex...
This week brought a burst of excitement around Criteo as takeover chatter swirled and the stock jumped. We break down...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
When SK Hynix opened its largest-ever share sale, demand overwhelmed the supply, and investors wanted billion more. T...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
End your week with clarity. This Friday reads roundup translates market happenings into actionable ideas for your por...